153 related articles for article (PubMed ID: 16245444)
1. [Hypoxia in malignant tumors the target for clostridial therapeutic gene strategies].
Wallner G; Misiuna P; Cygan W; Cygan Z
Pol Merkur Lekarski; 2005 Aug; 19(110):242-4. PubMed ID: 16245444
[TBL] [Abstract][Full Text] [Related]
2. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
[TBL] [Abstract][Full Text] [Related]
3. Clostridium as a tumor-specific delivery system of therapeutic proteins.
Theys J; Landuyt AW; Nuyts S; Van Mellaert L; Lambin P; Anné J
Cancer Detect Prev; 2001; 25(6):548-57. PubMed ID: 12132875
[TBL] [Abstract][Full Text] [Related]
4. Increasing specificity of anti-tumor therapy: cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters.
Nuyts S; Theys J; Landuyt W; van Mellaert L; Lambin P; Anné J
Anticancer Res; 2001; 21(2A):857-61. PubMed ID: 11396175
[TBL] [Abstract][Full Text] [Related]
5. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis.
Liu SC; Minton NP; Giaccia AJ; Brown JM
Gene Ther; 2002 Feb; 9(4):291-6. PubMed ID: 11896468
[TBL] [Abstract][Full Text] [Related]
6. Application of beta-lactamase-dependent prodrugs in clostridial-directed enzyme therapy (CDEPT): a proposal.
Tirandaz H; Hamedi J; Marashi SA
Med Hypotheses; 2006; 67(4):998-9. PubMed ID: 16797858
[No Abstract] [Full Text] [Related]
7. Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation.
Nuyts S; Van Mellaert L; Theys J; Landuyt W; Bosmans E; Anné J; Lambin P
Gene Ther; 2001 Aug; 8(15):1197-201. PubMed ID: 11509951
[TBL] [Abstract][Full Text] [Related]
8. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
9. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
Roy P; Waxman DJ
Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
[TBL] [Abstract][Full Text] [Related]
10. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
Pastorakova A; Hlubinova K; Altaner C
Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia response element-driven cytosine deaminase/5-fluorocytosine gene therapy system: a highly effective approach to overcome the dynamics of tumour hypoxia and enhance the radiosensitivity of prostate cancer cells in vitro.
Marignol L; Foley R; Southgate TD; Coffey M; Hollywood D; Lawler M
J Gene Med; 2009 Feb; 11(2):169-79. PubMed ID: 19051213
[TBL] [Abstract][Full Text] [Related]
12. Tumor hypoxia in cancer therapy.
Brown JM
Methods Enzymol; 2007; 435():297-321. PubMed ID: 17998060
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia targeting gene expression for breast cancer gene therapy.
Lee M
Adv Drug Deliv Rev; 2009 Aug; 61(10):842-9. PubMed ID: 19426773
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
17. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy.
Friedlos F; Lehouritis P; Ogilvie L; Hedley D; Davies L; Bermudes D; King I; Martin J; Marais R; Springer CJ
Clin Cancer Res; 2008 Jul; 14(13):4259-66. PubMed ID: 18594008
[TBL] [Abstract][Full Text] [Related]
18. Le morte du tumour: histological features of tumor destruction in chemo-resistant cancers following intravenous infusions of pathotropic nanoparticles bearing therapeutic genes.
Gordon EM; Chan MT; Geraldino N; Lopez FF; Cornelio GH; Lorenzo CC; Levy JP; Reed RA; Liu L; Hall FL
Int J Oncol; 2007 Jun; 30(6):1297-307. PubMed ID: 17487349
[TBL] [Abstract][Full Text] [Related]
19. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
[TBL] [Abstract][Full Text] [Related]
20. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
